Literature DB >> 27586327

Cell-Binding Assays for Determining the Affinity of Protein-Protein Interactions: Technologies and Considerations.

S A Hunter1, J R Cochran2.   

Abstract

Determining the equilibrium-binding affinity (Kd) of two interacting proteins is essential not only for the biochemical study of protein signaling and function but also for the engineering of improved protein and enzyme variants. One common technique for measuring protein-binding affinities uses flow cytometry to analyze ligand binding to proteins presented on the surface of a cell. However, cell-binding assays require specific considerations to accurately quantify the binding affinity of a protein-protein interaction. Here we will cover the basic assumptions in designing a cell-based binding assay, including the relevant equations and theory behind determining binding affinities. Further, two major considerations in measuring binding affinities-time to equilibrium and ligand depletion-will be discussed. As these conditions have the potential to greatly alter the Kd, methods through which to avoid or minimize them will be provided. We then outline detailed protocols for performing direct- and competitive-binding assays against proteins displayed on the surface of yeast or mammalian cells that can be used to derive accurate Kd values. Finally, a comparison of cell-based binding assays to other types of binding assays will be presented.
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell-binding assay; Equilibrium; K(d); KinExA; Ligand depletion; SPR; Yeast surface display

Mesh:

Substances:

Year:  2016        PMID: 27586327      PMCID: PMC6067677          DOI: 10.1016/bs.mie.2016.05.002

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  33 in total

1.  Optimal screening of surface-displayed polypeptide libraries.

Authors:  E T Boder; K D Wittrup
Journal:  Biotechnol Prog       Date:  1998 Jan-Feb

2.  Quantitative aspects of the reaction between insulin and insulin-binding antibody.

Authors:  S A BERSON; R S YALOW
Journal:  J Clin Invest       Date:  1959-11       Impact factor: 14.808

3.  Engineering antibody affinity by yeast surface display.

Authors:  David W Colby; Brenda A Kellogg; Christilyn P Graff; Yik A Yeung; Jeffrey S Swers; K Dane Wittrup
Journal:  Methods Enzymol       Date:  2004       Impact factor: 1.600

4.  A structure-based benchmark for protein-protein binding affinity.

Authors:  Panagiotis L Kastritis; Iain H Moal; Howook Hwang; Zhiping Weng; Paul A Bates; Alexandre M J J Bonvin; Joël Janin
Journal:  Protein Sci       Date:  2011-02-16       Impact factor: 6.725

Review 5.  Ligand binding assays at equilibrium: validation and interpretation.

Authors:  Edward C Hulme; Mike A Trevethick
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

6.  Introducing a biosensor based technology for real-time biospecific interaction analysis.

Authors:  U Jönsson; L Fägerstam; S Löfas; E Stenberg; R Karlsson; A Frostell; F Markey; F Schindler
Journal:  Ann Biol Clin (Paris)       Date:  1993       Impact factor: 0.459

Review 7.  Radioligand binding methods: practical guide and tips.

Authors:  D B Bylund; M L Toews
Journal:  Am J Physiol       Date:  1993-11

8.  Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting.

Authors:  H A Feldman
Journal:  Anal Biochem       Date:  1972-08       Impact factor: 3.365

9.  Yeast surface display for directed evolution of protein expression, affinity, and stability.

Authors:  E T Boder; K D Wittrup
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

10.  Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists.

Authors:  Douglas S Jones; Ping-Chuan Tsai; Jennifer R Cochran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-25       Impact factor: 11.205

View more
  17 in total

1.  Fab is the most efficient format to express functional antibodies by yeast surface display.

Authors:  Coline Sivelle; Raphaël Sierocki; Kelly Ferreira-Pinto; Stéphanie Simon; Bernard Maillere; Hervé Nozach
Journal:  MAbs       Date:  2018-05-24       Impact factor: 5.857

2.  A general model of multivalent binding with ligands of heterotypic subunits and multiple surface receptors.

Authors:  Zhixin Cyrillus Tan; Aaron S Meyer
Journal:  Math Biosci       Date:  2021-10-09       Impact factor: 2.144

3.  Affinity and Stability Analysis of Yeast Displayed Proteins.

Authors:  Charlotte U Zajc; Magdalena Teufl; Michael W Traxlmayr
Journal:  Methods Mol Biol       Date:  2022

4.  Engineering a potent inhibitor of matriptase from the natural hepatocyte growth factor activator inhibitor type-1 (HAI-1) protein.

Authors:  Aaron C Mitchell; Deepti Kannan; Sean A Hunter; R Andres Parra Sperberg; Cheryl H Chang; Jennifer R Cochran
Journal:  J Biol Chem       Date:  2018-01-31       Impact factor: 5.157

5.  Antitumor activity of an engineered decoy receptor targeting CLCF1-CNTFR signaling in lung adenocarcinoma.

Authors:  Jun W Kim; Cesar P Marquez; Kaja Kostyrko; Amanda L Koehne; Kieren Marini; David R Simpson; Alex G Lee; Stanley G Leung; Leanne C Sayles; Joseph Shrager; Irene Ferrer; Luis Paz-Ares; Melanie Hayden Gephart; Silvestre Vicent; Jennifer R Cochran; E Alejandro Sweet-Cordero
Journal:  Nat Med       Date:  2019-11-07       Impact factor: 53.440

6.  Identification of N-Terminally Diversified GLP-1R Agonists Using Saturation Mutagenesis and Chemical Design.

Authors:  Chelsea K Longwell; Stephanie Hanna; Nina Hartrampf; R Andres Parra Sperberg; Po-Ssu Huang; Bradley L Pentelute; Jennifer R Cochran
Journal:  ACS Chem Biol       Date:  2020-12-14       Impact factor: 5.100

7.  Depletion of PD-1-positive cells ameliorates autoimmune disease.

Authors:  Peng Zhao; Peng Wang; Shuyun Dong; Zemin Zhou; Yanguang Cao; Hideo Yagita; Xiao He; Song Guo Zheng; Simon J Fisher; Robert S Fujinami; Mingnan Chen
Journal:  Nat Biomed Eng       Date:  2019-03-04       Impact factor: 29.234

8.  Polymorphic Region-Specific Antibody for Evaluation of Affinity-Associated Profile of Chimeric Antigen Receptor.

Authors:  Chungyong Han; Beom K Choi; Seon-Hee Kim; Su-Jung Sim; Seongeun Han; Bomi Park; Yohei Tsuchiya; Masaki Takahashi; Young H Kim; Hyeon-Seok Eom; Tetsuya Kitaguchi; Hiroshi Ueda; Byoung S Kwon
Journal:  Mol Ther Oncolytics       Date:  2020-04-14       Impact factor: 7.200

9.  Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL.

Authors:  Matthew A Nix; Kamal Mandal; Huimin Geng; Neha Paranjape; Yu-Hsiu T Lin; Jose M Rivera; Makeba Marcoulis; Kristie L White; Jeffrey D Whitman; Sagar P Bapat; Kevin R Parker; Jonathan Ramirez; Anne Deucher; Paul Phojanokong; Veronica Steri; Faranak Fattahi; Byron C Hann; Ansuman T Satpathy; Aashish Manglik; Elliot Stieglitz; Arun P Wiita
Journal:  Cancer Discov       Date:  2021-03-16       Impact factor: 39.397

10.  Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis.

Authors:  Shiven Kapur; Adam P Silverman; Anne Z Ye; Niv Papo; Darren Jindal; Mark S Blumenkranz; Jennifer R Cochran
Journal:  Bioeng Transl Med       Date:  2017-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.